In one paragraphArticle in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Gusein A SadykhovPostovsky Institute of Organic Synthesis, Ural Branch of the Russian Academy of Sciences, S. Kovalevskoy Street, 22, Ekaterinburg 620137, Russia.
Danila V BelyaevPostovsky Institute of Organic Synthesis, Ural Branch of the Russian Academy of Sciences, S. Kovalevskoy Street, 22, Ekaterinburg 620137, Russia.
Ekaterina E KhramtsovaDepartment of Chemistry, Perm State University, Bukireva Street, 15, Perm 614990, Russia.ORCID 0000-0002-5851-3082 Diana V VakhrushevaUral Research Institute for Phthisiopulmonology-The Branch of National Medical Research Center for Phthisiopulmonology and Infection Diseases, 22 Parts'ezda Street, 50, Ekaterinburg 620039, Russia.ORCID 0000-0001-6085-6466 Svetlana Yu KrasnoborovaUral Research Institute for Phthisiopulmonology-The Branch of National Medical Research Center for Phthisiopulmonology and Infection Diseases, 22 Parts'ezda Street, 50, Ekaterinburg 620039, Russia.ORCID 0000-0002-1429-1676 Dmitry V DianovUral Research Institute for Phthisiopulmonology-The Branch of National Medical Research Center for Phthisiopulmonology and Infection Diseases, 22 Parts'ezda Street, 50, Ekaterinburg 620039, Russia.ORCID 0009-0002-1634-2796 Marina G PervovaPostovsky Institute of Organic Synthesis, Ural Branch of the Russian Academy of Sciences, S. Kovalevskoy Street, 22, Ekaterinburg 620137, Russia.
Gennady L RusinovPostovsky Institute of Organic Synthesis, Ural Branch of the Russian Academy of Sciences, S. Kovalevskoy Street, 22, Ekaterinburg 620137, Russia.
Egor V VerbitskiyPostovsky Institute of Organic Synthesis, Ural Branch of the Russian Academy of Sciences, S. Kovalevskoy Street, 22, Ekaterinburg 620137, Russia.ORCID 0000-0002-1482-206X Valery N CharushinPostovsky Institute of Organic Synthesis, Ural Branch of the Russian Academy of Sciences, S. Kovalevskoy Street, 22, Ekaterinburg 620137, Russia.ORCID 0000-0002-9140-358X Funding
Russian Science Foundation 24-23-00084
6 · The paper itselfAbstract
The synthetic approach based on a sequence of Buchwald-Hartwig cross-coupling and annulation through intramolecular oxidative cyclodehydrogenation has been used for the construction of novel 4-alkyl-4
Indexed as
Antitubercular AgentsMycobacterium tuberculosisQuinoxalinesMicrobial Sensitivity TestsMolecular Docking SimulationStructure-Activity RelationshipAntitubercular AgentsQuinoxalinesantitubercular activityBuchwald–Hartwig aminationC–H functionalizationindolo[2,3-b]quinoxalines
Identifiers
PMID39796223
PMCPMC11720412
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390